Droloxifene (drol) a new antietrogen in advanced breast cancer , double blind dose finding study (for the drl 002 international study) - Hegg, Roberto; Aguiar, L F; Souza, Aurélio Zecchi de; Teixeira, L. C.; Malzyner, A; Deschenes, L; Pritchard, K I; Pinotti, José Aristodemo (World Congress of Gynaecology and Obstetrics (Figo), 1991)